Functional role of microvesicles in gastrointestinal malignancies

Annals of Translational Medicine

Volumn 1, Issue 1, 2013, Pages

  McDaniel, Kelly ^a   Correa, Robert ^a   Zhou, Tianhao ^a,b   Johnson, Christopher ^a,c,d   Francis, Heather ^a,c,d   Glaser, Shannon ^a,c,d   Venter, Julie ^d   Alpini, Gianfranco ^a,c,d   Meng, Fanyin ^a,c,d  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b SHANGHAI UNIVERSITY OF ENGINEERING SCIENCE   (China)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Gastrointestinal malignancies; Microvesicles (MVs)

Indexed keywords

EID: 85015507110     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2012.10.01     Document Type: Article

References (50)

1. Muralidharan-Chari V, Clancy JW, Sedgwick A, et al. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010;123:1603-11.
2. Muralidharan-Chari V, Clancy J, Plou C, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009;19:1875-85.
3. Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008;9:871-81.
4. Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009;21:575-81.
5. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009;19:43-51.
6. Graves LE, Ariztia EV, Navari JR, et al. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004;64:7045-9.
7. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007;21:157-71.
8. Smalley DM, Sheman NE, Nelson K, et al. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res 2008;7:2088-96.
9. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110:13-21.
10. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 2005;10:822-37.
11. Köppler B, Cohen C, SchlöndorffD, et al. Differential mechanisms of microparticle transfer toB cells and monocytes: anti-inflammatory propertiesof microparticles. Eur J Immunol 2006;36:648-60.
12. Mack M, Kleinschmidt A, Brühl H, et al. Transfer of the chemokine receptor CCR5 between cells by membranederived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000;6:769-75.
13. Schweitzer JK, D'Souza-Schorey C. Finishing the job: cytoskeletal and membrane events bring cytokinesis to an end. Exp Cell Res 2004;295:1-8.
14. Chazal N, Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev 2003;67:226-37, table of contents.
15. Morita E, Sundquist WI. Retrovirus budding. Annu Rev Cell Dev Biol 2004;20:395-425.
16. Corbeil D, Röper K, Fargeas CA, et al. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2001;2:82-91.
17. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438:932-6.
18. Charras GT, Yarrow JC, Horton MA, et al. Nonequilibration of hydrostatic pressure in blebbing cells. Nature 2005;435:365-9.
19. Del Conde I, Shrimpton CN, Thiagarajan P, et al. Tissuefactor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005;106:1604-11.
20. Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 2003;278:41573-6.
21. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006;55:808-18.
22. Farsad K, De Camilli P. Mechanisms of membrane deformation. Curr Opin Cell Biol 2003;15:372-81.
23. Liepins A. Possible role of microtubules in tumor cell surface membrane shedding, permeability, and lympholysis. Cell Immunol 1983;76:120-8.
24. Hugel B, Martínez MC, Kunzelmann C, et al. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-7.
25. Huttner WB, Zimmerberg J. Implications of lipid microdomains for membrane curvature, budding and fission. Curr Opin Cell Biol 2001;13:478-84.
26. Zimmerberg J, Kozlov MM. How proteins produce cellular membrane curvature. Nat Rev Mol Cell Biol 2006;7:9-19.
27. Bausch AR, Ziemann F, Boulbitch AA, et al. Local measurements of viscoelastic parameters of adherent cell surfaces by magnetic bead microrheometry. Biophys J 1998;75:2038-49.
28. D'Souza-Schorey C, Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006;7:347-58.
29. Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-6.
30. Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9.
31. Valenti R, Huber V, Iero M, et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007;67:2912-5.
32. Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasLbearing microvesicles. J Exp Med 2002;195:1303-16.
33. Hotary K, Li XY, Allen E, et al. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 2006;20:2673-86.
34. Ginestra A, Miceli D, Dolo V, et al. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 1999;19:3439-45.
35. Ginestra A, La Placa MD, Saladino F, et al. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 1998;18:3433-7.
36. Rauch U, Antoniak S. Tissue factor-positive microparticles in blood associated with coagulopathy in cancer. Thromb Haemost 2007;97:9-10.
37. Hron G, Kollars M, Weber H, et al. Tissue factorpositive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007;97:119-23.
38. Taraboletti G, D'Ascenzo S, Giusti I, et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 2006;8:96-103.
39. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694.
40. Kim CW, Lee HM, Lee TH, et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 2002;62:6312-7.
41. Zwicker JI, Furie BC, Furie B. Cancer-associated thrombosis. Crit Rev Oncol Hematol 2007;62:126-36.
42. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999;96:2311-5.
43. Jansa R, Sustar V, Frank M, et al. Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases. Blood Cells Mol Dis 2008;41:124-32.
44. Bazhenov DV. Intercellular relations in esophageal muscle tissues. Arkh Anat Gistol Embriol 1987;93:77-82.
45. Bateson MC, Hopwood D, Milne G, et al. Oesophageal epithelial ultrastructure after incubation with gastrointestinal fluids and their components. J Pathol 1981;133:33-51.
46. Baran J, Baj-Krzyworzeka M, Weglarczyk K, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010;59:841-50.
47. Rikhof B, van der Graaf WT, Meijer C, et al. Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL. Br J Cancer 2008;99:1600-6.
48. Fonsato V, Collino F, Herrera MB, et al. Human Liver Stem Cell-Derived Microvesicles Inhibit Hepatoma Growth in SCID Mice by Delivering Antitumor MicroRNAs. Stem Cells 2012;30:1985-98.
49. Hong SN, Kim JH, Choe WH, et al. Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: a case-control study. Dig Dis Sci 2012;57:753-63.
50. Huber V, Fais S, Iero M, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005;128:1796-804.